Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Phubio Technology is a biotechnology company and contract research organization (CRO) specializing in DNA-encoded library (DEL) technology. Based in Chengdu, China, the company provides a comprehensive platform for the synthesis and screening of massive chemical libraries containing billions of DNA-tagged small molecules. This technology enables the rapid and cost-effective identification of high-affinity ligands for a wide range of biological targets, significantly accelerating the early drug discovery process. Phubio offers services to global pharmaceutical and biotech partners, ranging from library construction to hit identification and lead optimization. The company is a key player in the Chengdu Tianfu Bio-Town, contributing to the region's growing expertise in innovative drug discovery tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Fubi.